9124
J. S. Yada6 et al. / Tetrahedron Letters 44 (2003) 9121–9124
indole (1 mmol) in acetonitrile (10 mL) was stirred at
Acknowledgements
room temperature for the specified time (see Table 1).
After completion of the reaction as indicated by TLC, the
reaction mixture was quenched with water (15 mL) and
extracted with dichloromethane (2×10 mL). Evaporation
of the solvent followed by purification on silica gel
(Merck, 100–200 mesh, ethyl acetate-hexane, 0.5–9.5)
afforded pure indol-3ylbenzoquinone. Spectral data for
B.V. S. and T. S. thank CSIR, New Delhi for the award
of fellowships.
References
selected
products:
3g:
2-(2-methyl-3-indolyl)-1,4-
hydroquinone (see Table 1): solid, mp 106–108°C, 1H
NMR (CDCl3): l 2.40 (s, 3H), 4.40 (brs, 1H, OH), 4.60
(brs, 1H, OH), 6.70–6.80 (m, 2H), 6.90 (d, 1H, J=8.0
Hz), 7.05–7.20 (m, 2H), 7.30–7.45 (m, 2H), 8.0 (brs, 1H,
NH). 13C NMR (50 MHz, CDCl3): l 12.9, 109.9, 110.8,
114.3, 116.1, 116.8, 118.3, 118.9, 120.5, 122.9, 128.3,
133.3, 135.6, 147.8, 149.8. IR (KBr): w 3279, 2923, 1636,
1565, 1457, 1294, 1010, 774 cm−1. EIMS: m/z (%): 239
M+ (30), 155 (10), 141 (20), 199 (100), 82 (95), 47 (80).
HRMS calcd for C15H13NO2: 239.0946. Found: 239.0989.
4h: 2,5-bis(3-indolyl)-1,4-hydroquinone (see Table 1):
1. (a) Arai, K.; Yamamoto, Y. Chem. Pharm. Bull. 1990, 38,
2929–2932; (b) Kaji, A.; Saito, R.; Nomura, M.;
Miyamoto, K.; Kiriyama, N. Biol. Pharm. Bull. 1998, 21,
945–949.
2. (a) Arai, K.; Shimizu, S.; Taguchi, Y.; Yamamoto, Y.
Chem. Pharm. Bull. 1981, 29, 991; (b) Shimizu, S.;
Yamamoto, Y.; Koshimura, S. Chem. Pharm. Bull. 1982,
30, 1896–1899; (c) Kaji, A.; Iwata, T.; Kiriyama, N.;
Wakusawa, S.; Miyamoto, K. Chem. Pharm. Bull. 1994,
42, 1682.
3. (a) Alvi, K. A.; Pu, H.; Luche, M.; Rice, A.; App, H.;
McMahon, G.; Dare, H.; Margolis, B. J. Antibiot. 1999,
52, 215–223; (b) Kaji, A.; Saito, R.; Nomura, M.;
Miyamoto, K.; Kiriyama, N. Anticancer Res. 1997, 17,
3675–3679.
4. Zhang, B.; Salituro, G.; Szalkowski, D.; Li, Z.; Zhang,
Y.; Royo, I.; Vilella, D.; Diez, M. T.; Pelaez, F.; Ruby,
C.; Kendall, R. L.; Mao, X.; Griffin, P.; Calaycay, J.;
Zierath, J. R.; Heck, J. V.; Smith, R. G.; Moller, D. E.
Science 1999, 284, 974–977.
1
solid, mp 116–118°C, H NMR (CDCl3): l 4.80 (brs, 2H,
OH), 7.05 (d, 2H, J=1.7 Hz), 7.05–7.45 (m, 8H), 7.80 (d,
2H, J=8.1 Hz), 8.30 (brs, 2H, NH). 13C NMR (50 MHz,
CDCl3): l 112.8, 113.9, 116.9, 117.6, 120.2, 122.2, 124.2,
126.5, 127.2, 137.3, 147.9. IR (KBr): w 3398, 1618, 1457,
1337, 1096, 743 cm−1. EIMS: m/z (%): 340 M+ (100), 257
(10), 228 (12), 156 (15), 142 (70), 84 (80), 47 (20). HRMS
calcd for C22H16N2O2: 340.3689. Found: 340.3095. 5l:
2-methyl-5-(2-methyl-3-indolyl)benzo-1,4-quinone
(see
Table 1): solid, mp 196–197°C, 1H NMR (200 MHz,
CDCl3): l 2.15 (s, 3H), 2.40 (s, 3H), 6.70 (s, 1H), 6.85 (s,
1H), 7.05–7.20 (m, 2H), 7.25–7.30 (m, 1H), 7.45–7.50 (m,
1H), 8.10 (brs, 1H, NH). 13C NMR (50 MHz, CDCl3): l
13.6, 15.4, 105.9, 111.2, 119.2, 120.1, 121.5, 127.6, 132.9,
133.8, 138.3, 142.3, 145.4, 146.3, 187.2, 187.8. IR (KBr):
w 3398, 1616, 1457, 1219, 772 cm−1. EIMS: m/z (%): 251
M+ (40), 186 (50), 154 (30), 121 (40), 77 (100), 41 (40). 6p:
2-(2-methyl-3-indolyl)-1,4-naphthoquinone (see Table 1):
5. (a) Brewer, D.; Jerram, W.; Taylor, A. Can. J. Microbiol.
1968, 14, 861; (b) Sekita, S. Chem. Pharm. Bull. 1983, 31,
2998; (c) Kaji, A.; Saito, R.; Hata, Y.; Kiriyama, N.
Chem. Pharm. Bull. 1999, 47, 77–82.
6. (a) Mohlau, R.; Redlich, R. Ber. Dtsch. Chem. Ges. 1911,
44, 3605–3608; (b) Bu’Lock, J. D.; Harley-Mason, J. J.
Chem. Soc. 1951, 703; (c) Maiti, A. K.; Bhattacharya, P.
J. Chem. Res. (S) 1997, 424–425.
7. (a) Pirrung, M. C.; Park, K.; Li, Z. Org. Lett. 2001, 3,
365–367; (b) Pirrung, M. C.; Deng, L.; Li, Z.; Park, K. J.
Org. Chem. 2002, 67, 8374–8388.
8. Repichet, S.; Zwick, A.; Vendier, L.; Le Roux, C.;
Dubac, J. Tetrahedron Lett. 2002, 43, 993–995.
9. Leonard, M. N.; Wieland, L. C.; Mohan, R. S. Tetra-
hedron 2002, 58, 8373–8397.
1
solid, mp 180°C, H NMR (CDCl3): l 2.50 (s, 3H), 7.10
(s, 1H), 7.15–7.20 (m, 2H), 7.25–7.30 (m, 1H), 7.50–7.60
(m, 1H), 7.70–7.80 (m, 2H), 8.10–8.20 (m, 2H), 8.25 (brs,
1H, NH). 13C NMR (50 MHz, CDCl3): l 14.2, 107.6,
111.1, 119.7, 121.2, 122.6, 126.3, 127.4, 128.0, 132.6,
133.2, 133.9, 134.1, 135.1, 135.9, 137.5, 144.8, 185.2,
185.7. IR (KBr): w 3274, 2922, 1739, 1634, 1457, 1254,
714 cm−1. EIMS: m/z (%): 287 M+ (20), 270 (15), 230
(100). HRMS calcd for C19H13NO2: 287.0946. Found:
287.0918.
10. Harris, G. D., Jr.; Nguyen, A.; App, H.; Hirth, P.;
McMahon, G.; Tang, C. Org. Lett. 1999, 1, 431–433.
11. General procedure: A mixture of the p-quinone (2.5
mmol) and Bi(OTf)3 (2 mol%) or Sc(OTf)3 (5 mol%) and